Lv1
30 积分 2021-07-25 加入
MRI-based quantification of intratumoral heterogeneity for intrahepatic mass-forming cholangiocarcinoma grading: a multicenter study
1个月前
已完结
Genetic instability in Hodgkin's lymphoma
1个月前
已关闭
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
1个月前
已完结
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
1个月前
已完结
HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study
2个月前
已完结
Hepatic Pseudoprogression after Treatment with Nectin-4–Targeted Antibody–Drug Conjugate
2个月前
已完结
Outcomes of small‐cell versus large‐cell gastroenteropancreatic neuroendocrine carcinomas: A population‐based study
3个月前
已完结
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
3个月前
已完结
Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States
6个月前
已完结
Gender Differences in Premature Coronary Artery Disease (from the National Data from the NHANES Database)
7个月前
已完结
皖公网安备34019202002308
